| Zontal–Bruker: investment, 202305 acquisition $14.8m of Zontal by Bruker |
2023-05-08 |
| Yair Technologies–Nuclera: eProtein Discovery system, 202505– collab distribution by Yair Or Technologies Ltd in Israel |
2025-05-06 |
| Wyatt Technology–Waters: investment, 202302–202305 acquisition $1.36b in cash of Wyatt by Waters |
2023-02-15 |
| Weezion–Mérieux: investment, 202206 investment €2m from bioMérieux for a 4.26% share accompanied by technical assistance |
2022-06-01 |
| Weezion–Mérieux: in-vitro diagnostics, 202206– collab technical assistance from bioMérieux to develop MS-based sepsis IVD |
2022-06-01 |
| Waters–Plasmion: ionisation technology, 202402– collab co-marketing/promotion of SICRIT ion source with Waters Acquity QDa + Select Series Cycli IMS |
2024-02-21 |
| Waters–Kyungpook National Univ: mass spectrometry, 202012– collab research expansion with S Kim using Cyclic IMS system for crude oil analysis |
2020-12-08 |
| Waters–Heidrick & Struggles: recruitment services, 202007 supply service placement of Udit Batra as CEO of Waters |
2020-07-01 |
| Virscidian–Dotmatics: investment, 202409 acquisition of Virscidian by Dotmatics |
2024-09-25 |
| Variolytics–SEVERAL: investment, 202212 seed financing round €7-digit from HTGF + FTTF + business angels |
2022-12-07 |
| ValitaCell–Danaher: investment, 202209 acquisition of ValitaCell by Beckman Coulter Life Sciences |
2022-09-13 |
| Univ Zurich–Bruker: NMR spectrometer, 202412 supply 1.2 GHz Ascend NMR spectrometer to Swiss High-field NMR Facility at UZH |
2024-12-20 |
| Univ Pennsylvania–Agilent: grant, 202011– Thought Leader Award to Carl H June + M Milone at School of Medicine for cancer cell therapy |
2020-11-17 |
| Univ London–Enamine: chemical compound libraries, 202509– supply + collab Enamine to supply fluorinated compounds for FBDD to ICR |
2025-09-23 |
| Univ Kiel–Bruker: CellScape XR platform, 2002602 supply + collab research UKSH Kiel has been early customer |
2026-02-25 |
| Univ Guelph–Bruker: NMR spectrometer, 202008 supply existent of 400 MHz NMR spectrometer + Fourier 80 benchtop NRM system |
2020-08-24 |
| Univ Bochum–North Rhine-Westphalia (govt): grant, 202006– grant €4m from NRW + EFRO for establishment CESAR Center for Antibiotics Research with LDC |
2020-06-18 |
| Univ Bochum–Max Planck: antibiotics research, 202006– collab establishment CESAR Center for Antibiotics Research at Univ Bochum with LDC |
2020-06-18 |
| Univ Belfast–Agilent: mass spectrometer, 202106 supply 7850 ICP-MS instrument as part of Thought Leader Award grant to QUB IGFS |
2021-06-01 |
| Univ Belfast–Agilent: mass spectrometer, 202106 supply 6546 LC-Q/TOF instrument as part of Thought Leader Award grant to QUB IGFS |
2021-06-01 |
| Univ Belfast–Agilent: LC system, 202106 supply 1290 Infinity II LC System as part of Thought Leader Award grant to QUB IGFS |
2021-06-01 |
| Univ Belfast–Agilent: grant, 202106– Thought Leader Award to Prof Chris Elliott at QUB IGFS for food safety analysis |
2021-06-01 |
| UniteLabs–SEVERAL: investment, 202504 pre-seed financing round €2.77m led by NAP |
2025-04-03 |
| UniteLabs–Push Ventures: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor PUSH |
2025-04-03 |
| UniteLabs–OMA Business Angels: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor OMA Business Angels |
2025-04-03 |
| UniteLabs–NAP: investment, 202504 pre-seed financing round totalling €2.77m incl lead investor NAP |
2025-04-03 |
| UniteLabs–Lana Ventures: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor LANA Ventures |
2025-04-03 |
| UniteLabs–Acurio Ventures: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor Acurio Ventures |
2025-04-03 |
| Umlaut.bio–SEVERAL: investment, <=202505 seed financing round €2m with HTGF + LBBW Venture Capital + L-Bank |
2025-05-13 |
| Umlaut.bio–LBBW: investment, <=202505 seed financing round incl investor LBBW Venture Capital |
2025-05-13 |
| Umlaut.bio–High-Tech Gründerfonds: investment, <=202505 seed financing round incl investor HTGF |
2025-05-13 |
| Umlaut.bio–Baden-Würrtemberg (govt): investment, <=202505 seed financing round incl investor L-Bank via InnoGrowth BW programme |
2025-05-13 |
| TrueMass–Scott Partnership: public relations, 202110 service existent by Scott PR |
2021-10-26 |
| TrueMass–OTHER: investment, 2020– significant seed funding from business angels |
2020-01-01 |
| Trace Analytics–908 Devices: investment, 202208 acquisition $15.3m upfront cash + $2m cash milestones |
2022-08-09 |
| Tome Biosciences–SEVERAL: investment, 202312 financing rounds Series A + B $213m announced at launch |
2023-12-12 |
| Tome Biosciences–Bruker: investment, 202312 financing rounds Series A + B totalling $213m incl $10m from investor Bruker Corp 7/23 |
2023-07-26 |
| TOFwerk–Bruker: investment, 202601 acquisition of remaining 60% ownership stake €na by Bruker |
2026-01-08 |
| TOFwerk–Bruker: investment, 202205 minority investment in TOFwerk by Bruker |
2022-05-10 |
| Thermo Fisher–Sidis: cell sorting technology, 202102 acquisition cell sorting assets incl Bigfoot Spectral Cell Sorter + 40 employees from Propel Labs |
2021-02-17 |
| Thermo Fisher–ChromSword: HPLC software, –202108 collab developm + launch of Vanquish Method Development HPLC + UHPLC system using ChromSword s/w |
2021-08-16 |
| Thermo Fisher–Carbon Engineering: analytical technology, 202109 collab existent direct air capture technology to reduce CO2 emissions |
2021-09-23 |
| Thermo Fisher–Biomatter Designs: enzyme design, 202408 supply existent customer Thermo Fisher |
2024-08-05 |
| Thermo Fisher–Bico: MS-based single cell proteomics, 202111– co-marketing Cellenion’s cellenONE + proteoCHIP with Orbitrap MS systems + TMT technology |
2021-11-15 |
| Tescan–Shimadzu: investment, 202512– acquisition $678m of Tescan a.s. from Carlyle |
2025-12-25 |
| Tescan–Carlyle: investment, 202301 acquisition of Tescan by Carlyle |
2023-01-01 |
| Ten23 Health–Bionter: particle counting, 202305– collab developm of methods incl installation of EVE particle counter at Ten23 Heatlh |
2023-05-02 |
| Tecan–UgenTec: laboratory automation, 202102– collab product integration of Tecan workstations with FastFinder qPCR-s/w for sale in dx markets |
2021-02-04 |
| Tecan–Nvidia: AI-based lab management, 202603– strategic collab AI-powered lab automation platforms |
2026-03-17 |
| Tecan–Labforward: laboratory software, 2020– collab integration of Tecan detection devices with Labfolder LIMS |
2020-01-01 |
| Targos Molecular Pathology–Discovery Life Sciences: investment, 202105 acquisition of Targos by Discovery Life Sciences |
2021-05-18 |
| Tagomics–Zyme Communications: public relations, 202411 service existent by Zyme |
2024-11-20 |
| Tagomics–SEVERAL: investment, <202402 pre-seed financing round £1.6m (incl grant from Innovate UK) |
2024-02-21 |
| Tagomics–SEVERAL: investment, 202402 financing round £6.7m led by Calculus Capital |
2024-02-21 |
| Tagomics–Agilent: genomic technology, 202411– collab co-marketing agreem of Interlace multiomics services using Agilent genomic profiling products |
2024-11-20 |
| Sysmex–SAFIA Technologies: mycotoxin immunoassays, 202402– distribution ww of tests for food/agri by Sysmex Partec using SAFIA tech + flow cytometry |
2024-02-15 |
| Synexa Life Sciences–Waters: mass spectrometer, 202506 supply + collab as one of first customers for new Xevo TQ Absolute XR mass spectrometer |
2025-06-10 |
| Syncell–Taiwania Capital: investment, 202412 financing round Series A totalling $15m incl lead investor Taiwania Capital Bio Fund |
2024-12-11 |
| Syncell–SEVERAL: investment, 202412 financing round Series A $15m led by Taiwania Capital Bio Fund bringing total raised to $30m |
2024-12-11 |
| Sygnature Discovery–Rothschild & Co: investment, 202106 significant €na investment by Five Arrows Principal Investments |
2021-06-29 |
| Swift Biosciences–Danaher: investment, 202103 acquisition €na of Swift Biosciences by Integrated DNA Technologies |
2021-03-11 |
| Sterling Pharma Solutions–Thermo Fisher: LC system, 202003 supply early customer for Vanquish Core HPLC System |
2020-03-02 |
| Stem Genomics–Clean Biologics: investment, 202606 acquisition €na of Stem Genomics by Clean Cells backed by Archimed |
2026-06-18 |
| Stellaromics–Stanford Univ: investment, 202502 financing round Series B totalling $80m incl co-investor Stanford University Ventures |
2025-02-11 |
| Stellaromics–SEVERAL: investment, 202502 financing round Series B $80m led by Catalyst4 |
2025-02-11 |
| Stellaromics–Oak Street Communications: public relations, 202502 service existent Oak Street is media contact for Stellaromics |
2025-02-11 |
| Stellaromics–Catalyst4: investment, 202502 financing round Series B totalling $80m incl lead investor Catalyst4 |
2025-02-11 |
| Standard BioTools–Illumina: investment, 202506– acquisition of SomaLogic by Illumina for $350m cash upfront + $75m milestones |
2025-06-23 |
| SPT Labtech–EQT: investment, 202206– acquisition £650m of SPT Labtech by EQT IX Fund from Battery Ventures |
2022-06-22 |
| SpinChip Diagnostics–Mérieux: investment, 202501– acquisition of remaining 80% of SpinChip for €111m in cash by bioMérieux |
2025-01-13 |
| Spectricity–SEVERAL: investment, 202108 financing round Series B €14m |
2021-08-03 |
| Sopat–Endress+Hauser: investment, 202601 acquisition €na of Sopat GmbH + sub Parsum GmbH by Endres+Hauser |
2026-01-01 |
| SomaLogic–Ziff Capital: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Ziff Capital Healthcare Ventures |
2020-12-22 |
| SomaLogic–Standard BioTools: investment, 202310–202401 reverse merger with former SomaCare shareholders owning 57% of combined company |
2023-10-04 |
| SomaLogic–SEVERAL: investment, 202012 financing round Series A 2nd closing additional $81m bringing total Series A to $204m or $214m |
2020-12-22 |
| SomaLogic–SEVERAL: investment, 202011 financing round Series A initial closing $121m led by Casdin Capital |
2020-11-25 |
| SomaLogic–Revelation Partners: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Revelation Partners |
2020-12-22 |
| SomaLogic–Redmile Group: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Redmile Group |
2020-12-22 |
| SomaLogic–Novartis: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Novartis |
2020-12-22 |
| SomaLogic–NEC: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl NEC Solution Innovators Ltd |
2020-12-22 |
| SomaLogic–Millenium Management: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Millennium Management |
2020-12-22 |
| SomaLogic–Logos Capital: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Logos Capital |
2020-12-22 |
| SomaLogic–Janus Henderson: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Janus Henderson Investors |
2020-12-22 |
| SomaLogic–Intermountain Ventures: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Intermountain Ventures |
2020-12-22 |
| SomaLogic–Boston Millennia Partners: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Boston Millenia Partners |
2020-12-22 |
| SomaLogic–Amgen: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Amgen |
2020-12-22 |
| Solventum–Thermo Fisher: investment, 202502– acquisition $4.1b in cash of purification + filtration business by Thermo Fisher |
2025-02-25 |
| Slack Technologies–Salesforce: investment, 202012– acquisition $27.7b in cash + shares of Slack by Salesforce ANNOUNCED |
2020-12-01 |
| Sirion Biotech–PerkinElmer: investment, 202106– acquisition by PerkinElmer ANNOUNCED |
2021-06-22 |
| Sigsense Technologies–Agilent: investment, 202407 acquisition €na of Sigsense by Agilent |
2024-07-29 |
| Siemens–Biognosys: MS-based biomarker discovery, 202104– strategic agreem marker discovery using HRM-MS for Dx assay development with S Healthineers |
2021-04-13 |
| Siemens–ASG Superconductors: magnetic resonance imaging, 202301– collab integration of ASG MRI magnets >7T in Siemens Healthineers UFH MRI systems |
2023-01-18 |
| Shimadzu–Tescan: electron microscopes, 202407– collab business alliance adding Tescan products to Shimadzu analytical portfolio |
2024-07-01 |
| Shimadzu–Plasmion: ionisation technology, 2019– collab exchange of tech info + lending of Shimadzu porducts + development of SICRIT applications |
2019-01-01 |
| Shimadzu–Newomics: electrospray ionisation technology, 202608– collab co-marketing Newomics technologies with Shimadzu Q-TOF + TQ LC-MS systems |
2026-08-24 |
| Scitara–SEVERAL: investment, 202201 financing round Series B $15m led by Northpond Ventures |
2022-01-11 |
| Scitara–SEVERAL: investment, 202101 financing round Series A $5m led by Northpond Ventures |
2021-01-28 |
| Scitara–Scott Partnership: public relations, 202201 service existent by Scott PR |
2022-01-11 |
| Scitara–Northpond Ventures: investment, 202201 financing round Series B totalling $15m incl existing + lead investor Northpond Ventures |
2022-01-11 |
| Scitara–Northpond Ventures: investment, 202101 financing round Series A totalling $5m incl lead investor Northpond Ventures |
2021-01-28 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spec-capital-portal-logo.svg){kind=logo}
Deal: Collaboration or Financing
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
